25 XP   0   0   10

PainChek Ltd
Buy, Hold or Sell?

Let's analyse Painchek together

PenkeI guess you are interested in PainChek Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PainChek Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PainChek Ltd

I send you an email if I find something interesting about PainChek Ltd.

Quick analysis of Painchek (30 sec.)










What can you expect buying and holding a share of Painchek? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.01
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-35.0%

For what price can you sell your share?

Current Price per Share
A$0.03
Expected price per share
A$0.026 - A$0.032
How sure are you?
50%

1. Valuation of Painchek (5 min.)




Live pricePrice per Share (EOD)

A$0.03

Intrinsic Value Per Share

A$-0.06 - A$-0.03

Total Value Per Share

A$-0.06 - A$-0.03

2. Growth of Painchek (5 min.)




Is Painchek growing?

Current yearPrevious yearGrowGrow %
How rich?$431k$3.1m-$2.6m-621.9%

How much money is Painchek making?

Current yearPrevious yearGrowGrow %
Making money-$4.8m-$3.6m-$1.1m-24.5%
Net Profit Margin-388.5%-584.6%--

How much money comes from the company's main activities?

3. Financial Health of Painchek (5 min.)




4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#103 / 120

Most Revenue
#102 / 120

Most Profit
#79 / 120

Most Efficient
#110 / 120

What can you expect buying and holding a share of Painchek? (5 min.)

Welcome investor! Painchek's management wants to use your money to grow the business. In return you get a share of Painchek.

What can you expect buying and holding a share of Painchek?

First you should know what it really means to hold a share of Painchek. And how you can make/lose money.

Speculation

The Price per Share of Painchek is A$0.029. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Painchek.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Painchek, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Painchek.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-10.3%0.00-10.3%0.00-7.8%0.00-9.5%0.00-7.6%
Usd Book Value Change Per Share0.00-5.7%0.00-5.7%0.00-4.7%0.00-0.7%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-5.7%0.00-5.7%0.00-4.7%0.00-0.7%0.00-0.1%
Usd Price Per Share0.02-0.02-0.02-0.05-0.04-
Price to Earnings Ratio-5.40--5.40--8.01--28.88--25.42-
Price-to-Total Gains Ratio-9.84--9.84--13.39-5,048.69-2,530.54-
Price to Book Ratio61.21-61.21-9.50-41.39-31.39-
Price-to-Total Gains Ratio-9.84--9.84--13.39-5,048.69-2,530.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0187108
Number of shares53445
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (53445 shares)-87.59-10.78
Gains per Year (53445 shares)-350.37-43.11
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-350-3600-43-53
20-701-7100-86-96
30-1051-10600-129-139
40-1401-14100-172-182
50-1752-17600-216-225
60-2102-21100-259-268
70-2453-24600-302-311
80-2803-28100-345-354
90-3153-31600-388-397
100-3504-35100-431-440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.01.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%8.05.00.061.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%6.04.00.060.0%8.05.00.061.5%

Fundamentals of Painchek

About PainChek Ltd

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets for facial scan that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia and pre-verbal infants. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-04-02 22:46:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PainChek Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Painchek earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Painchek to the Health Information Services industry mean.
  • A Net Profit Margin of -388.5% means that $-3.89 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PainChek Ltd:

  • The MRQ is -388.5%. The company is making a huge loss. -2
  • The TTM is -388.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-388.5%TTM-388.5%0.0%
TTM-388.5%YOY-584.6%+196.0%
TTM-388.5%5Y-2,118.3%+1,729.8%
5Y-2,118.3%10Y-120,853.1%+118,734.8%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-388.5%-21.3%-367.2%
TTM-388.5%-20.1%-368.4%
YOY-584.6%-29.8%-554.8%
5Y-2,118.3%-34.6%-2,083.7%
10Y-120,853.1%-42.2%-120,810.9%
1.1.2. Return on Assets

Shows how efficient Painchek is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Painchek to the Health Information Services industry mean.
  • -271.0% Return on Assets means that Painchek generated $-2.71 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PainChek Ltd:

  • The MRQ is -271.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -271.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-271.0%TTM-271.0%0.0%
TTM-271.0%YOY-86.0%-185.0%
TTM-271.0%5Y-131.8%-139.2%
5Y-131.8%10Y-566.2%+434.4%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-271.0%-6.5%-264.5%
TTM-271.0%-6.0%-265.0%
YOY-86.0%-5.4%-80.6%
5Y-131.8%-5.4%-126.4%
10Y-566.2%-8.2%-558.0%
1.1.3. Return on Equity

Shows how efficient Painchek is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Painchek to the Health Information Services industry mean.
  • -1,133.7% Return on Equity means Painchek generated $-11.34 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PainChek Ltd:

  • The MRQ is -1,133.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1,133.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,133.7%TTM-1,133.7%0.0%
TTM-1,133.7%YOY-118.6%-1,015.1%
TTM-1,133.7%5Y-337.0%-796.7%
5Y-337.0%10Y-238.9%-98.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,133.7%-6.8%-1,126.9%
TTM-1,133.7%-6.8%-1,126.9%
YOY-118.6%-7.4%-111.2%
5Y-337.0%-9.1%-327.9%
10Y-238.9%-9.6%-229.3%

1.2. Operating Efficiency of PainChek Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Painchek is operating .

  • Measures how much profit Painchek makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Painchek to the Health Information Services industry mean.
  • An Operating Margin of -449.4% means the company generated $-4.49  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PainChek Ltd:

  • The MRQ is -449.4%. The company is operating very inefficient. -2
  • The TTM is -449.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-449.4%TTM-449.4%0.0%
TTM-449.4%YOY-775.6%+326.1%
TTM-449.4%5Y-2,898.2%+2,448.7%
5Y-2,898.2%10Y-44,606.1%+41,707.9%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ-449.4%-22.7%-426.7%
TTM-449.4%-16.4%-433.0%
YOY-775.6%-22.8%-752.8%
5Y-2,898.2%-18.4%-2,879.8%
10Y-44,606.1%-32.1%-44,574.0%
1.2.2. Operating Ratio

Measures how efficient Painchek is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 5.49 means that the operating costs are $5.49 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PainChek Ltd:

  • The MRQ is 5.494. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.494. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.494TTM5.4940.000
TTM5.494YOY8.756-3.261
TTM5.4945Y30.375-24.880
5Y30.37510Y481.075-450.700
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4941.370+4.124
TTM5.4941.385+4.109
YOY8.7561.389+7.367
5Y30.3751.398+28.977
10Y481.0751.331+479.744

1.3. Liquidity of PainChek Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Painchek is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 1.30 means the company has $1.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PainChek Ltd:

  • The MRQ is 1.303. The company is just able to pay all its short-term debts.
  • The TTM is 1.303. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.303TTM1.3030.000
TTM1.303YOY3.623-2.320
TTM1.3035Y3.747-2.444
5Y3.74710Y4.166-0.419
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3031.811-0.508
TTM1.3031.813-0.510
YOY3.6232.055+1.568
5Y3.7472.589+1.158
10Y4.1662.589+1.577
1.3.2. Quick Ratio

Measures if Painchek is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Painchek to the Health Information Services industry mean.
  • A Quick Ratio of 1.28 means the company can pay off $1.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PainChek Ltd:

  • The MRQ is 1.276. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.276. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.276TTM1.2760.000
TTM1.276YOY3.597-2.321
TTM1.2765Y3.729-2.453
5Y3.72910Y4.142-0.413
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2761.059+0.217
TTM1.2761.223+0.053
YOY3.5971.813+1.784
5Y3.7291.998+1.731
10Y4.1422.076+2.066

1.4. Solvency of PainChek Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Painchek assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Painchek to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.76 means that Painchek assets are financed with 76.1% credit (debt) and the remaining percentage (100% - 76.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PainChek Ltd:

  • The MRQ is 0.761. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.761. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.761TTM0.7610.000
TTM0.761YOY0.275+0.486
TTM0.7615Y0.361+0.400
5Y0.36110Y1.151-0.790
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7610.380+0.381
TTM0.7610.383+0.378
YOY0.2750.399-0.124
5Y0.3610.411-0.050
10Y1.1510.450+0.701
1.4.2. Debt to Equity Ratio

Measures if Painchek is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Painchek to the Health Information Services industry mean.
  • A Debt to Equity ratio of 318.4% means that company has $3.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PainChek Ltd:

  • The MRQ is 3.184. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.184. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.184TTM3.1840.000
TTM3.184YOY0.379+2.804
TTM3.1845Y0.931+2.253
5Y0.93110Y0.565+0.366
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1840.595+2.589
TTM3.1840.577+2.607
YOY0.3790.607-0.228
5Y0.9310.709+0.222
10Y0.5650.616-0.051

2. Market Valuation of PainChek Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Painchek generates.

  • Above 15 is considered overpriced but always compare Painchek to the Health Information Services industry mean.
  • A PE ratio of -5.40 means the investor is paying $-5.40 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PainChek Ltd:

  • The EOD is -6.263. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.399. Based on the earnings, the company is expensive. -2
  • The TTM is -5.399. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.263MRQ-5.399-0.864
MRQ-5.399TTM-5.3990.000
TTM-5.399YOY-8.007+2.608
TTM-5.3995Y-28.876+23.477
5Y-28.87610Y-25.424-3.452
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-6.263-1.570-4.693
MRQ-5.399-2.188-3.211
TTM-5.399-2.131-3.268
YOY-8.007-3.673-4.334
5Y-28.876-5.005-23.871
10Y-25.424-4.981-20.443
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PainChek Ltd:

  • The EOD is -7.487. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.454. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.454. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.487MRQ-6.454-1.033
MRQ-6.454TTM-6.4540.000
TTM-6.454YOY-6.525+0.071
TTM-6.4545Y-47.828+41.374
5Y-47.82810Y-37.020-10.808
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD-7.487-1.438-6.049
MRQ-6.454-1.799-4.655
TTM-6.454-2.834-3.620
YOY-6.525-5.673-0.852
5Y-47.828-4.197-43.631
10Y-37.020-3.814-33.206
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Painchek is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 61.21 means the investor is paying $61.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PainChek Ltd:

  • The EOD is 71.003. Based on the equity, the company is expensive. -2
  • The MRQ is 61.209. Based on the equity, the company is expensive. -2
  • The TTM is 61.209. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD71.003MRQ61.209+9.793
MRQ61.209TTM61.2090.000
TTM61.209YOY9.496+51.713
TTM61.2095Y41.387+19.822
5Y41.38710Y31.391+9.996
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD71.0031.776+69.227
MRQ61.2091.873+59.336
TTM61.2091.943+59.266
YOY9.4962.978+6.518
5Y41.3873.998+37.389
10Y31.3914.198+27.193
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of PainChek Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of PainChek Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%-0.002-18%0.000-88%0.000-98%
Book Value Per Share--0.0000.0000%0.003-86%0.003-85%0.002-77%
Current Ratio--1.3031.3030%3.623-64%3.747-65%4.166-69%
Debt To Asset Ratio--0.7610.7610%0.275+177%0.361+111%1.151-34%
Debt To Equity Ratio--3.1843.1840%0.379+740%0.931+242%0.565+463%
Dividend Per Share----0%-0%-0%-0%
Eps---0.005-0.0050%-0.003-24%-0.004-8%-0.003-26%
Free Cash Flow Per Share---0.004-0.0040%-0.004+11%-0.003-29%-0.002-49%
Free Cash Flow To Equity Per Share---0.002-0.0020%-0.003+45%0.000-94%0.000-3254%
Gross Profit Margin--1.2451.2450%1.289-3%1.239+1%1.126+11%
Intrinsic Value_10Y_max---0.031--------
Intrinsic Value_10Y_min---0.059--------
Intrinsic Value_1Y_max---0.002--------
Intrinsic Value_1Y_min---0.004--------
Intrinsic Value_3Y_max---0.007--------
Intrinsic Value_3Y_min---0.014--------
Intrinsic Value_5Y_max---0.013--------
Intrinsic Value_5Y_min---0.026--------
Market Cap47439070.464+14%40895750.40040895750.4000%45803240.448-11%139307284.163-71%92816995.108-56%
Net Profit Margin---3.885-3.8850%-5.846+50%-21.183+445%-1208.531+31004%
Operating Margin---4.494-4.4940%-7.756+73%-28.982+545%-446.061+9825%
Operating Ratio--5.4945.4940%8.756-37%30.375-82%481.075-99%
Pb Ratio71.003+14%61.20961.2090%9.496+545%41.387+48%31.391+95%
Pe Ratio-6.263-16%-5.399-5.3990%-8.007+48%-28.876+435%-25.424+371%
Price Per Share0.029+14%0.0250.0250%0.028-11%0.085-71%0.057-56%
Price To Free Cash Flow Ratio-7.487-16%-6.454-6.4540%-6.525+1%-47.828+641%-37.020+474%
Price To Total Gains Ratio-11.417-16%-9.842-9.8420%-13.389+36%5048.695-100%2530.542-100%
Quick Ratio--1.2761.2760%3.597-65%3.729-66%4.142-69%
Return On Assets---2.710-2.7100%-0.860-68%-1.318-51%-5.662+109%
Return On Equity---11.337-11.3370%-1.186-90%-3.370-70%-2.389-79%
Total Gains Per Share---0.003-0.0030%-0.002-18%0.000-88%0.000-98%
Usd Book Value--431078.121431078.1210%3112066.713-86%2836983.628-85%1874870.421-77%
Usd Book Value Change Per Share---0.002-0.0020%-0.001-18%0.000-88%0.000-98%
Usd Book Value Per Share--0.0000.0000%0.002-86%0.002-85%0.001-77%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.0030%-0.002-24%-0.003-8%-0.002-26%
Usd Free Cash Flow---4088218.827-4088218.8270%-4528955.592+11%-2908871.941-29%-2101552.344-49%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.003+11%-0.002-29%-0.001-49%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.002+45%0.000-94%0.000-3254%
Usd Market Cap30607688.263+14%26385938.15826385938.1580%29552250.737-11%89881059.742-71%59885525.244-56%
Usd Price Per Share0.019+14%0.0160.0160%0.018-11%0.055-71%0.037-56%
Usd Profit---4887214.506-4887214.5060%-3690888.537-24%-4411246.852-10%-3549431.985-27%
Usd Revenue--1257825.7881257825.7880%631371.428+99%455006.525+176%231160.901+444%
Usd Total Gains Per Share---0.002-0.0020%-0.001-18%0.000-88%0.000-98%
 EOD+5 -3MRQTTM+0 -0YOY+11 -235Y+6 -2810Y+8 -26

4.2. Fundamental Score

Let's check the fundamental score of PainChek Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.263
Price to Book Ratio (EOD)Between0-171.003
Net Profit Margin (MRQ)Greater than0-3.885
Operating Margin (MRQ)Greater than0-4.494
Quick Ratio (MRQ)Greater than11.276
Current Ratio (MRQ)Greater than11.303
Debt to Asset Ratio (MRQ)Less than10.761
Debt to Equity Ratio (MRQ)Less than13.184
Return on Equity (MRQ)Greater than0.15-11.337
Return on Assets (MRQ)Greater than0.05-2.710
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of PainChek Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.440
Ma 20Greater thanMa 500.030
Ma 50Greater thanMa 1000.030
Ma 100Greater thanMa 2000.033
OpenGreater thanClose0.031
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Gross Profit  -130113-17-407-424165-259971713



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,795
Total Liabilities2,127
Total Stockholder Equity668
 As reported
Total Liabilities 2,127
Total Stockholder Equity+ 668
Total Assets = 2,795

Assets

Total Assets2,795
Total Current Assets2,772
Long-term Assets23
Total Current Assets
Cash And Cash Equivalents 2,512
Net Receivables 202
Other Current Assets 58
Total Current Assets  (as reported)2,772
Total Current Assets  (calculated)2,772
+/-0
Long-term Assets
Property Plant Equipment 23
Long-term Assets  (as reported)23
Long-term Assets  (calculated)23
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,127
Long-term Liabilities0
Total Stockholder Equity668
Total Current Liabilities
Short-term Debt -757
Accounts payable 499
Other Current Liabilities 871
Total Current Liabilities  (as reported)2,127
Total Current Liabilities  (calculated)613
+/- 1,514
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock35,180
Retained Earnings -48,580
Other Stockholders Equity 14,068
Total Stockholder Equity (as reported)668
Total Stockholder Equity (calculated)668
+/-0
Other
Capital Stock35,180
Cash And Equivalents2,512
Cash and Short Term Investments 2,512
Common Stock Shares Outstanding 1,289,989
Current Deferred Revenue757
Liabilities and Stockholders Equity 2,795
Net Debt -2,512
Net Invested Capital 668
Net Tangible Assets 668
Net Working Capital 645
Property Plant and Equipment Gross 162



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-30
> Total Assets 
222
2,425
1,392
960
2,337
115
2,690
3,673
4,749
6,216
11,811
6,652
2,795
2,7956,65211,8116,2164,7493,6732,6901152,3379601,3922,425222
   > Total Current Assets 
0
2,354
1,180
181
430
115
2,687
3,668
4,734
6,198
11,792
6,626
2,772
2,7726,62611,7926,1984,7343,6682,6871154301811,1802,3540
       Cash And Cash Equivalents 
183
2,321
1,133
141
112
80
2,630
3,606
4,562
6,120
11,420
6,141
2,512
2,5126,14111,4206,1204,5623,6062,630801121411,1332,321183
       Net Receivables 
0
25
13
29
306
34
45
56
161
69
316
437
202
202437316691615645343062913250
       Inventory 
0
0
0
0
0
0
0
0
0
9
57
48
0
048579000000000
   > Long-term Assets 
0
71
213
779
1,907
0
3
4
16
18
18
26
23
23261818164301,907779213710
       Property Plant Equipment 
25
71
213
779
1,907
0
3
4
16
18
18
26
23
23261818164301,9077792137125
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000
> Total Liabilities 
58
37
97
156
860
1,030
207
448
628
2,087
3,567
1,829
2,127
2,1271,8293,5672,0876284482071,030860156973758
   > Total Current Liabilities 
58
37
97
156
860
1,030
207
448
628
2,087
3,567
1,829
2,127
2,1271,8293,5672,0876284482071,030860156973758
       Short-term Debt 
0
0
0
0
250
750
0
0
0
-1,250
-1,045
0
-757
-7570-1,045-1,2500007502500000
       Short Long Term Debt 
0
0
0
0
0
750
0
0
0
0
0
0
0
000000075000000
       Accounts payable 
17
8
48
42
551
131
148
287
202
231
325
275
499
4992753252312022871481315514248817
       Other Current Liabilities 
41
29
49
114
59
148
59
161
426
606
2,196
747
871
8717472,1966064261615914859114492941
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
202
231
325
275
0
027532523120200000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000
> Total Stockholder Equity
164
2,388
1,296
804
1,477
-915
2,483
3,225
4,121
4,128
8,244
4,823
668
6684,8238,2444,1284,1213,2252,483-9151,4778041,2962,388164
   Common Stock
200
2,825
2,825
3,123
5,500
8,129
8,503
13,710
17,756
21,262
30,739
32,484
35,180
35,18032,48430,73921,26217,75613,7108,5038,1295,5003,1232,8252,825200
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 
0
10
16
13
13
39
2,743
3,088
3,201
12,095
12,790
13,345
14,068
14,06813,34512,79012,0953,2013,0882,74339131316100
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
2,743
3,088
3,201
12,095
12,790
13,345
14,068
14,06813,34512,79012,0953,2013,0882,743000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue1,950
Cost of Revenue-1,237
Gross Profit713713
 
Operating Income (+$)
Gross Profit713
Operating Expense-9,475
Operating Income-8,762-8,762
 
Operating Expense (+$)
Research Development3,817
Selling General Administrative3,033
Selling And Marketing Expenses1,858
Operating Expense9,4758,708
 
Net Interest Income (+$)
Interest Income6
Interest Expense-0
Other Finance Cost-0
Net Interest Income6
 
Pretax Income (+$)
Operating Income-8,762
Net Interest Income6
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,623-8,901
EBIT - interestExpense = -8,762
-8,623
-7,575
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-8,762-8,623
Earnings Before Interest and Taxes (EBITDA)-8,745
 
After tax Income (+$)
Income Before Tax-8,623
Tax Provision-0
Net Income From Continuing Ops-7,575-8,623
Net Income-7,575
Net Income Applicable To Common Shares-7,575
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,712
Total Other Income/Expenses Net139-6
 

Technical Analysis of Painchek
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Painchek. The general trend of Painchek is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Painchek's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PainChek Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.032 < 0.032 < 0.032.

The bearish price targets are: 0.028 > 0.026 > 0.026.

Tweet this
PainChek Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PainChek Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PainChek Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PainChek Ltd. The current macd is -0.000082.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Painchek price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Painchek. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Painchek price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
PainChek Ltd Daily Moving Average Convergence/Divergence (MACD) ChartPainChek Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PainChek Ltd. The current adx is 17.02.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Painchek shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1